Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
Sodium DNA Macromolecule obtained through bio-technology, based on denatured, purified, depolymerized and neutralized polydeoxyribonucleotides fragments
Community on your terms Virtual health and wellness sessions and patient groups are there when you want them
Does CAT deficiency happen more often in a certain ethnic group
By buying a high-dose pen and taking tiny doses, they can stretch a single months supply into several months
L-theanine offers a pathway to calm, focused energy through brain chemical changes